Quantum leap.

1,249 unicorns, 1 map.

AI's recruiting spree.

 

View in browser

December 14, 2024

Hi there,

 

Here are this week's top research briefs.

ICYMI

 

15 tech trends to watch closely in 2025

The future of LLMs. Caregiving humanoid robots. Crypto’s baby steps. We use CB Insights data to uncover 15 emerging trends that will shape the tech landscape for years to come.

2025-tech-trends

Autonomous vehicles are back: How transportation and mobility companies can capitalize on the recent resurgence

We examine what’s driving recent investment, partnership, and exit activity in the autonomous driving space to identify leaders and determine the market's direction.

image3-Dec-12-2024-03-21-50-7945-PM

Digital Health 50: The most promising digital health startups of 2024

The Digital Health 50 is CB Insights’ annual list of the most promising digital health startups in the world.
DH-50-MM-122024

$1B+ Market Map: The world’s 1,249 unicorn companies in one infographic

Nearly 1 in 2 new unicorns is an AI company. We visualize every billion-dollar startup around the globe and break down emerging areas of opportunity.

UnicornMM-FI-112024-3

Customer-Exclusive Research

 

The quantum information market map: The companies working on quantum computing, post-quantum cryptography, and more

From commercializing quantum computer applications in industries like finance and healthcare to defending against quantum algorithms with new post-quantum cryptography standards, the quantum information landscape is rapidly becoming more complex. We break down the tech companies defining the quantum future.

Quantum-information-landscape-market-map_2024

The genAI recruiter is coming: How AI agents & copilots are making hiring more efficient and who to watch next

From screening resumes to conducting assessments and handling questions, we map the new wave of companies automating employee hiring and break down what HR leaders need to know about the market. 

gen-ai-recruiter-12052024

Inside the AI drug discovery arms race: Record M&A activity, a biologics funding spree, and more

We analyze funding and acquisitions data, clinical progress, and partnership strategies to help pharma companies and investors navigate the maturing AI landscape in drug discovery.

Screenshot 2024-12-11 at 6.21.45 PM

Have a great weekend.

 

I love you. 

 

 Anand

@asanwal

Co-Founder & Exec Chair

 

P.S. If you didn't catch it, our analysts discussed the trends shaping AI's future. Click here for the recording. 

Get started with CB Insights

Start your free trial

CB Insights' emerging technology insights platform provides all the

analysis and data from this newsletter. Our data is the easiest way to discover and respond to emerging tech. 

Was this email forwarded to you? Sign up here

X
LinkedIn
CB-Insights-Icon-Light

Copyright © 2024 CB Insights, All rights reserved.

498 7th Avenue, NY, CB Insights, New York,10018

About Us | Update Preferences | Research | Newsletter